Navigation Links
Rigel Announces Fourth Quarter and Year End 2011 Financial Results
Date:3/6/2012

studies with R348 by the end of 2012.  
  • R256, inhaled interleukin 13 (IL13) signaling inhibitor for chronic asthma.  This selective and potent IL13 inhibitor is in preclinical studies aimed at evaluating its ability to reduce airway inflammation generally associated with chronic asthma and potentially improve the health of the lungs.
  • Intravenous inhibition of GDF8 signaling for muscle strength.  One of Rigel's programs aimed at muscle health, this preclinical program is focused on inhibiting the GDF8 signaling cascade which leads to loss of muscle in a variety of chronic disease states, but particularly in regard to loss of diaphragm muscle mass and strength (atrophy) associated with respiratory ventilator use.  Preclinical studies have shown that inhibiting GDF8 signaling may be therapeutically useful to prevent muscle loss and improve muscle function.  
  • Oral AMP-activated Kinase (AMPK) activation for muscle endurance.  Patients with chronic illnesses such as chronic heart failure, COPD or diabetes, often experience a decrease in strength and increase in fatigue due to muscle myopathy.  Rigel is conducting preclinical studies of an oral activator of AMPK to improve the body's energy utilization and restore muscle endurance in chronically ill subjects.  

  • About Rigel (www.rigel.com)

    Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 c
    '/>"/>

    SOURCE Rigel Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Rigel Announces Participation at Two Investor Conferences
    2. Rigel Announces Initiation of Clinical Trials in Two Immunology Programs
    3. Rigel to Present at Oppenheimer Annual Healthcare Conference
    4. Rigel Announces Third Quarter 2011 Financial Results
    5. Rigel to Present at Two Upcoming Investor Conferences
    6. Rigel to Present at Wells Fargo Securities Healthcare Conference
    7. Rigel to Present at Jefferies Global Healthcare Conference
    8. Rigel Announces Pricing of Public Offering of Common Stock
    9. Rigel Announces Proposed Public Offering of Common Stock
    10. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
    11. Rigel Announces First Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... , July 30, 2014  There is still ... organization,s success. The 10th Annual Institute for Supply ... for Excellence in Supply Management is open for ... the understanding and importance of supply management by ... and best supply management practices.  Entries are due ...
    (Date:7/30/2014)... 30, 2014 Advanced Photonix ® (NYSE MKT: ... 2014) financial results on Monday, August 11, 2014. A press ... close of the market and the Company will host a ... p.m. EDT on the same day. Participating in ... Director), Rob Risser (COO and Director), and ...
    (Date:7/30/2014)... Mass., July 30, 2014  Hologic, Inc. (NASDAQ: ... third fiscal quarter ended June 28, 2014. ... Revenues increased 1.0% to $632.6 million, reflecting operational growth ... compared to the same period in the prior year. ... business segments. , Breast Health revenues grew 3.5%. ...
    Breaking Medicine Technology:Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17
    ... Reportlinker.com announces that a new market research ... Pharmaceuticals: Global Industry Guide ... Pharmaceuticals: Global Industry Guide is ... analysis covering the Pharmaceuticals industry. It includes ...
    ... 2012 Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE ... three lead drugs (Zertane™ completed two phase ... licensing distribution of these drugs and engaged in further ... interim review of the first 50% of patients enrolled ...
    Cached Medicine Technology:Pharmaceuticals: Global Industry Guide 2Pharmaceuticals: Global Industry Guide 3Pharmaceuticals: Global Industry Guide 4Pharmaceuticals: Global Industry Guide 5Pharmaceuticals: Global Industry Guide 6Pharmaceuticals: Global Industry Guide 7Pharmaceuticals: Global Industry Guide 8Pharmaceuticals: Global Industry Guide 9Pharmaceuticals: Global Industry Guide 10Pharmaceuticals: Global Industry Guide 11Pharmaceuticals: Global Industry Guide 12Pharmaceuticals: Global Industry Guide 13Pharmaceuticals: Global Industry Guide 14Pharmaceuticals: Global Industry Guide 15Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule 2Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule 3Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule 4
    (Date:7/30/2014)... Ticket Down is a reputable source for ... MI on Saturday, August 2nd. Two of the most ... competing on American soil on Aug. 2 when Manchester United and ... The home of the University of Michigan is also known as ... all of American sports and has also hosted numerous other monumental ...
    (Date:7/30/2014)... Good Neighbor Community Services announced that ... of Innovations with Ed Begley Jr, airing later ... times TBA. , In this segment, viewers will ... to redefine the traditional approach to serving the ... passion, innovation, determination, excellence, and collaboration, Good Community ...
    (Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 ... shed excess pounds may want to team up with their ... in a supervised behavioral modification program gained less weight than ... (an average difference of about four pounds over two years). ... two years, according to the study. "In a nutshell, ...
    (Date:7/30/2014)... Volunteers from the Church of Scientology of ... summer with massive distribution of Truth About Drugs ... volunteers on Strøget, the famous Copenhagen walking street. ... and its ambiance, some quarter of a million people ... , These activities are part of a coordinating ...
    (Date:7/30/2014)... fuel cancer as well as evolutionary changes in a ... occur randomly throughout the genome. , However, recent studies ... of multiple mutations that arise simultaneously and in close ... are frequently found in regions where chromosomal rearrangements take ... Cell Reports , may one day lead to new ...
    Breaking Medicine News(10 mins):Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 2Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 3Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 4Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 4Health News:Biologists describe mechanism promoting multiple DNA mutations 2
    ... Sources Preferred Over Imports), FRESNO, Calif., Oct. 16 ... their confidence in the food supply has,decreased over the ... California Olive Industry. The registered dieticians and nutritionists ... saying that when presented with a,choice, they prefer food ...
    ... NASHVILLE, Tenn., Oct. 16 HCA today announced the,appointment ... West Division,which is based in Las Vegas, effective Jan. ... retirement. As Far West Division President, Rogers will ... currently include nine,hospitals and seven ambulatory surgery centers with ...
    ... Feature Special Performances by John Legend, Joss Stone, ... Patti Labelle & ... for Cancer,Research will honor four outstanding individuals at the 2007 Angel ... BET Networks Debra L. Lee, Chief Hematologic Oncology,Memorial Sloan-Kettering Cancer Center ...
    ... but some people may prefer one option over the ... with "mid-range" -- or intermediate -- coronary artery disease ... help decide between angioplasty to open blocked arteries or ... say. , The long-term safety of the two procedures ...
    ... be the main cause of chronic gastritis and peptic ulcer ... evidence of H pylori infection in over 90% of cases ... the reason for low incidence of H pylori infection in ... this issue was recently reported in the November 7 issue ...
    ... with behind-the-wheel training can significantly improve their driving performance, ... of The Journal of Gerontology: Medical Sciences ... by Yale University,s Richard Marottoli examined 126 drivers aged ... classroom instruction and two hours of behind-the-wheel training (based ...
    Cached Medicine News:Health News:Dieticians & Nutritionists Report Decreased Confidence in Food Supply 2Health News:Bryan R. Rogers Appointed President of Far West Division 2Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 2Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 3Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 4Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 5Health News:Angioplasty Equals Bypass Surgery for Heart Patients: Study 2Health News:Angioplasty Equals Bypass Surgery for Heart Patients: Study 3Health News:A low prevalence of H pylori in HIV-positive patients 2
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: